Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lava Therapeutics N.V.
(NQ:
LVTX
)
1.900
+0.080 (+4.40%)
Streaming Delayed Price
Updated: 3:59 PM EST, Nov 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
29,201
Open
1.870
Bid (Size)
1.820 (2)
Ask (Size)
2.020 (8)
Prev. Close
1.820
Today's Range
1.780 - 1.900
52wk Range
1.160 - 6.470
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
LVTX Stock Earnings: LAVA Therapeutics Beats EPS for Q2 2024
August 20, 2024
LVTX stock results show that LAVA Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
LAVA Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
June 20, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
Performance
YTD
+8.39%
+8.39%
1 Month
+12.43%
+12.43%
3 Month
+8.57%
+8.57%
6 Month
-38.31%
-38.31%
1 Year
+58.33%
+58.33%
More News
Read More
LAVA Announces Annual Meeting of Shareholders
June 10, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
May 30, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
What 5 Analyst Ratings Have To Say About LAVA Therapeutics
August 23, 2023
Via
Benzinga
LVTX Stock Earnings: LAVA Therapeutics Beats EPS, Misses Revenue for Q1 2024
May 21, 2024
Via
InvestorPlace
LAVA Provides Business Updates and Reports First Quarter 2024 Financial Results
May 21, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
May 06, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LVTX Stock Earnings: LAVA Therapeutics Misses EPS, Misses Revenue for Q4 2023
March 20, 2024
Via
InvestorPlace
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
March 20, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
Via
FinancialNewsMedia
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments
March 05, 2024
From
FN Media Group LLC
Via
GlobeNewswire
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
March 05, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
January 29, 2024
Via
AB Newswire
Topics
Retirement
Exposures
Pension
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet (Donald Trump Has Re-Entered The Chat)
January 26, 2024
Via
Benzinga
Topics
Government
Exposures
Political
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 26, 2024
Via
InvestorPlace
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
January 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 25, 2024
Via
Benzinga
Dow Surges Over 100 Points; US GDP Growth Tops Estimates
January 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?
January 25, 2024
Via
Benzinga
LAVA Therapeutics Announces Collaboration with Merck & Co., Inc., Rahway, NJ, USA to Evaluate LAVA-1207 in Combination with KEYTRUDA®
January 25, 2024
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
November 16, 2023
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LAVA Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LAVA Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results
August 22, 2023
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
LAVA Therapeutics to Participate in the H.C. Wainwright Immune Cell Engager Virtual Conference
August 14, 2023
From
LAVA Therapeutics N.V.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
